Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
41 Patents
#225 in New York, NY
#520 in New York
#8,447 in US
#16,725 in the World
Molecular Insight Pharmaceuticals, Inc.
Forward Citations = 536
20 inventors:
New York, NY, United States of America
Molecular Insight Pharmaceuticals, Inc.
% Expired Patents = 29.3
CIPO Patents = 3
EPO Patents = 16
Trademarks = 2
Forward Citations = 536
Loading Chart...
Loading Chart...
20 inventors (with patents filed for the assignee):
John W Babich (37 out of 63 patents)
Craig N Zimmerman (25 out of 37 patents)
Kevin P Maresca (20 out of 22 patents)
4. John L Joyal (20 out of 20 patents)
5. Genliang Lu (16 out of 30 patents)
6. Shawn Hillier (11 out of 11 patents)
7. John Marquis (6 out of 6 patents)
8. Jian-cheng Wang (4 out of 4 patents)
9. Jason Moss (2 out of 2 patents)
10. Machinani Rao (2 out of 2 patents)
11. David R Elmaleh (1 out of 93 patents)
12. Robert N Hanson (1 out of 14 patents)
13. Chris Barone (1 out of 1 patent)
14. James Kronauge (1 out of 1 patent)
15. Miles P Smith (1 out of 3 patents)
Core Competencies:
Radiopharmaceuticals
PSMA-targeted Therapies
Imaging Agents
Triazine Compounds
Heterodimers
Carbonic Anhydrase IX
Metal Complexes
Diagnostic Imaging
Fatty Acid Analogues
Dendrimers
Drug Delivery
Organ Protection
41 patents:
5. 11167049 - Organ protection in PSMA-targeted radionuclide therapy of prostate cancer (2021-11-09),
7. 10668174 - Organ protection in PSMA-targeted radionuclide therapy of prostate cancer (2020-06-02),
Company Overview
Molecular Insight Pharmaceuticals, Inc. is a New York-based company specializing in the development of innovative radiopharmaceuticals and radioimaging agents. The organization focuses on advanced therapeutic modalities, particularly in PSMA-targeted therapy, which is pivotal for treating prostate cancer. Their expertise extends to the design and synthesis of complex compounds, including heterodimers, technetium and rhenium complexes, and dendrimers, aimed at enhancing diagnostic and therapeutic outcomes in oncology.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Molecular Insight Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/molecular-insight-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
16 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]